Skip to main content
  1. Life
  2. Health & Fitness
  3. Healthcare

FDA approves Botox for chronic migraines

See also

On October 15, 2010, the FDA approved Botox injection (onabotulinumtoxinA) to prevent headaches in adults with chronic migraine. Chronic migraine is defined as having a history of migraine headaches and experiencing a headache on 15 or more days in a month.

Botox (onabotulinumtoxinA) used to treat chronic migraine is given every 12 weeks as multiple injections around the head and neck. Allergan Inc., the manufacturer of Botox, says that the treatment is administered by a physician or other qualified medical professional in a series of 31 injections in seven specific sites in the head and neck. This treatment is meant to dull future headache symptoms.

The most common side effects of Botox injections are neck pain and headache. Also, the FDA has placed a “boxed warning” on Botox injection which says the effects of the botulinum toxin may spread from the injection site to other areas of the body causing symptoms similar to botulism. These symptoms may include difficulty swallowing and difficulty breathing which can be life-threatening.

The FDA has not had any reports of serious toxin spread in any of the approved uses for Botox injection.




  • Dan Savage
    Dan Savage cares about LGBT youth, bullying and saving lives
    Today's Buzz
  • Raku
    Teachers and students can use this summer to learn a new skill
    15 Photos
  • Beach body
    Fitness: Earn your beach body badge with bootcamp classes
    10 Photos
  • Greek wine
    Unwind with these delicious wines: The thrilling wines of Greece
    7 Photos
  • Mandy Moore
    Exclusive interview with Celebrity Mandy Moore concerning animal activism
    5 Photos
  • Educational family vacations
    Find out how to take an educational family vacation that doesn't break the bank
    9 Photos